SGLT2 Inhibitors and Treatment of Heart Failure in Severe Renal Insufficiency

Clinical trial NCT05737186 · TERMINATED

Trial details

NCT number: NCT05737186
Sponsor: Peking University People's Hospital
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure With Reduced Ejection Fraction Renal Insufficiency, Chronic

Start date: 2023-03-09
Primary completion: 2024-04-16
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.